Cargando…
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
BACKGROUND: The purpose of this study was to assess the effect of bevacizumab in maintaining intraocular pressure lowered by trabeculectomy in refractory open-angle glaucoma. METHODS: Thirty-seven eyes from 37 patients referring to Nikoukari Ophthalmology University Hospital in Tabriz were enrolled...
Autores principales: | Sedghipour, Mohammad-Reza, Mostafaei, Ali, Taghavi, Yousef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130917/ https://www.ncbi.nlm.nih.gov/pubmed/21750613 http://dx.doi.org/10.2147/OPTH.S17896 |
Ejemplares similares
-
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
por: Mostafaei, Ali
Publicado: (2011) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
por: Freiberg, Florentina Joyce, et al.
Publicado: (2013) -
Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy
por: Zarei, Reza, et al.
Publicado: (2016)